| |
 |
|
Class Information
Number: 514/31
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Carbohydrate (i.e., saccharide radical containing) doai > O-glycoside > Oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring > The hetero ring has 8 or more ring carbons > The hetero ring has 20 or more ring carbons (e.g., nystatin, etc.)
Description: Subject matter wherein the nonsaccharide hetero ring has 20 or more ring carbon atoms, e.g., nystatin, etc.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7612045 |
Compounds, compositions and methods for controlling biofilms and bacterial infections |
Nov. 3, 2009 |
| 7393837 |
Inhibition of PEX in the treatment of metabolic bone diseases |
Jul. 1, 2008 |
| 7326691 |
Compositions comprising amphotericin B, methods, and systems |
Feb. 5, 2008 |
| 7241741 |
Methods and compositions for the treatment of asthma and related disorders |
Jul. 10, 2007 |
| 7220726 |
Antifungal pimaricin compositions and therapeutic methods employing same |
May. 22, 2007 |
| 7205001 |
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
Apr. 17, 2007 |
| 7193706 |
Computer interfaced scanning fluorescence lifetime microscope applied to directed evolution |
Mar. 20, 2007 |
| 7179493 |
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
Feb. 20, 2007 |
| 7163703 |
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
Jan. 16, 2007 |
| 7153838 |
Pharmacologically acceptable solvent vehicles |
Dec. 26, 2006 |
| 7115576 |
Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate |
Oct. 3, 2006 |
| 7094431 |
Method of healing skin wounds in mammals and a composition therefor |
Aug. 22, 2006 |
| 7053061 |
Amphotercin B structured emulsion |
May. 30, 2006 |
| 7045507 |
Substituted tetracycline compounds as synergistic antifungal agents |
May. 16, 2006 |
| 7011826 |
Control of acidosis |
Mar. 14, 2006 |
| RE38984 |
Antifungal combination therapy |
Feb. 14, 2006 |
| 6919317 |
Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator |
Jul. 19, 2005 |
| 6914051 |
Penetrating antibiotic gel for soft tissue diseases |
Jul. 5, 2005 |
| 6884784 |
Diagnosis and management of infection caused by chlamydia |
Apr. 26, 2005 |
| 6875451 |
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
Apr. 5, 2005 |
| 6846837 |
Topical administration of basic antifungal compositions to treat fungal infections of the nails |
Jan. 25, 2005 |
| 6844004 |
Topical formulations of natamycin/pimaricin |
Jan. 18, 2005 |
| 6821526 |
Compositions and devices using a spinosyn compound for control of insects |
Nov. 23, 2004 |
| 6770290 |
Amphotericin B liposome preparation |
Aug. 3, 2004 |
| 6770306 |
Drugs for reducing vaginal acidity and treatment of vaginitis, and the use thereof |
Aug. 3, 2004 |
| 6756369 |
Diagnosis and management of infection caused by Chlamydia |
Jun. 29, 2004 |
| 6710033 |
Methods and treatment of multiple sclerosis |
Mar. 23, 2004 |
| 6667302 |
Heterocyclic topoisomerase poisons |
Dec. 23, 2003 |
| 6664239 |
Diagnosis and management of infection caused by Chlamydia |
Dec. 16, 2003 |
| 6664241 |
Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof |
Dec. 16, 2003 |
| 6660761 |
Method of treatment for fungal infections with a synergistic formulation of antifungal agents |
Dec. 9, 2003 |
| 6649595 |
Regulation of biological events using novel compounds |
Nov. 18, 2003 |
| 6593371 |
Treatment for wart and related disorders |
Jul. 15, 2003 |
| 6586407 |
Injectable pharmaceutical formulations for partricin derivatives |
Jul. 1, 2003 |
| 6579854 |
Diagnosis and management of infection caused by chlamydia |
Jun. 17, 2003 |
| 6576617 |
Direct action anti-mycotic |
Jun. 10, 2003 |
| 6562796 |
Derivatives of polyene macrolides and preparation and use thereof |
May. 13, 2003 |
| 6555566 |
Methods and materials for treating and preventing inflammation of mucosal tissue |
Apr. 29, 2003 |
| 6541455 |
Methods and kits for removing, treating, or preventing lice with driable pediculostatic agents |
Apr. 1, 2003 |
| 6518252 |
Method of treating aquatic animals with an antimicrobial agent and chelating agent |
Feb. 11, 2003 |
| 6509319 |
EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections |
Jan. 21, 2003 |
| 6468964 |
Control of acidic gut syndrome |
Oct. 22, 2002 |
| 6455518 |
Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-O-(2-hydroxyethyl)-rapamycin |
Sep. 24, 2002 |
| 6448233 |
Topical application of a combination of benzoyl peroxide and a second active ingredient |
Sep. 10, 2002 |
| 6432935 |
Pharmaceutical compositions, mainly vaginal suppository, containing many different active ingredients |
Aug. 13, 2002 |
| 6399607 |
Aminomethylene amide analogs of pyrazinamide with intracellular antimycobacterial activity against pyrazinamide-resistant mycobacteria combined with a rifamycin |
Jun. 4, 2002 |
| 6395711 |
Macrolides with antitumor activity |
May. 28, 2002 |
| 6369036 |
Antifungal composition |
Apr. 9, 2002 |
| 6362160 |
Immunophilin-binding agents prevent glutamate neurotoxicity associated with vascular stroke and neurodegenerative diseases |
Mar. 26, 2002 |
| 6350734 |
Methods and kits for removing, treating, or preventing lice with driable pediculostatic agents |
Feb. 26, 2002 |
|
|
|
